Fortrea Holdings FTRE
NASDAQ FTRE
$16.79 -0.27 (-1.58%)
As of: Sep 9, 2026 · 3:59 PM EDT

Fortrea Holdings (FTRE) Current Deferred Revenue (2022 - 2026)

Fortrea Holdings' (FTRE) quarterly Current Deferred Revenue came in at $502.7 million in Q2 2026, up 16656.67% on a YoY basis from N/an in Q2 2025, and up 4.45% quarter-over-quarter from $481.3 million in Q1 2026.

Analysis

Fortrea Holdings (FTRE) Current Deferred Revenue (2022 - 2026) Analysis & Trends

Fortrea Holdings (FTRE) has reported Current Deferred Revenue for 5 consecutive years, with $502.7 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Current Deferred Revenue rose 16656.67% year-over-year to $502.7 million; the trailing twelve-month figure through Jun 2026 stood at $502.7 million (up 16656.67% YoY), and the FY2025 full-year result was $473.8 million, up 34.11% from the prior year.
  • Current Deferred Revenue grew to $502.7 million in Q2 2026 per FTRE's latest filing, from $481.3 million in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $502.7 million in Q2 2026 and bottomed at $3.0 million in Q1 2025.
  • Historically, Current Deferred Revenue has averaged $289.2 million across 5 years, with a median of $268.2 million in 2022.
  • The sharpest annual moves came in 2025 and 2026: Current Deferred Revenue slumped 98.79% in 2025, then soared 16656.67% in 2026.
  • Over 5 years, Current Deferred Revenue stood at $271.5 million in 2022, then declined by 21.1% to $214.2 million in 2023, then jumped by 64.94% to $353.3 million in 2024, then jumped by 34.11% to $473.8 million in 2025, then rose by 6.1% to $502.7 million in 2026.
  • According to Business Quant data, Current Deferred Revenue over the past three periods registered $502.7 million, $481.3 million, and $473.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 44.06 Bn 42.11 Bn 1.44 Bn
2 Medpace Holdings 16.50 Bn 16.00 Bn 201.64 Mn
3 Charles River Laboratories International 13.77 Bn 13.62 Bn 452.07 Mn
4 Icon 12.62 Bn 11.69 Bn 479.29 Mn
5 Fortrea Holdings 1.68 Bn 1.51 Bn 139.20 Mn
6 Evotec SE 661.34 Mn 235.46 Mn -
7 Ginkgo Bioworks Holdings 442.79 Mn 358.26 Mn 18.44 Mn
8 Champions Oncology 72.49 Mn 72.62 Mn 7.03 Mn
9 MindWalk Holdings 61.66 Mn 53.38 Mn 1.82 Mn
10 VivoSim Labs 1.47 Mn 1.47 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 502.70 Mn
Mar 31, 2026 481.30 Mn
Dec 31, 2025 473.80 Mn
Sep 30, 2025 411.60 Mn
Jun 30, 2025 3.00 Mn
Mar 31, 2025 3.00 Mn
Dec 31, 2024 353.30 Mn
Sep 30, 2024 321.10 Mn
Jun 30, 2024 248.00 Mn
Mar 31, 2024 236.90 Mn
Dec 31, 2023 214.20 Mn
Sep 30, 2023 264.80 Mn
Jun 30, 2023 264.30 Mn
Dec 31, 2022 271.50 Mn